Searching for disease modifiers - PKC activation and HDAC inhibition - A dual drug approach to Alzheimer's disease that decreases Aβ production while blocking oxidative stress
Alan P. Kozikowski, Yihua Chen, Tapadar Subhasish, Nancy E. Lewin, Peter M. Blumberg, Zhenyu Zhong, Melissa A. D'Annibale, Weng Long Wang, Yong Shen, Brett Langley
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Searching for disease modifiers - PKC activation and HDAC inhibition - A dual drug approach to Alzheimer's disease that decreases Aβ production while blocking oxidative stress'. Together they form a unique fingerprint.